Millions of Medicare enrollees who buy stand-alone prescription drugs plans will see their average monthly premiums rise by 50% in 2027 — unless they switch to lower-cost plans.
bit.ly/4iey0XQ
Millions of Medicare enrollees who buy stand-alone prescription drugs plans will see their average monthly premiums rise by 50% in 2027 — unless they switch to lower-cost plans.
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase by switching to lower-cost plans.